ARROWHEAD PHARMACEUTICALS, INC. PP&E Disclosure
| Estimated Useful Lives | |||||
Buildings | 39 | ||||
| Research equipment | 5 | ||||
Manufacturing equipment | 7 to 10 | ||||
| Furniture | 7 | ||||
| Computers and software | 3 to 5 | ||||
| Leasehold improvements | Shorter of asset life or lease term | ||||
| September 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| (in thousands) | |||||||||||
| Land | $ | 2,996 | $ | 2,996 | |||||||
Buildings | 251,317 | 75,988 | |||||||||
| Research equipment | 62,758 | 65,353 | |||||||||
Manufacturing equipment | 18,588 | — | |||||||||
| Furniture | 5,594 | 5,594 | |||||||||
| Computers and software | 1,064 | 981 | |||||||||
| Leasehold improvements | 104,425 | 104,410 | |||||||||
| Construction in progress | 15,942 | 188,731 | |||||||||
| 462,684 | 444,053 | ||||||||||
| Less: Accumulated depreciation and amortization | (80,169) | (58,021) | |||||||||
| Property, plant and equipment, net | $ | 382,515 | $ | 386,032 | |||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Nov 25, 2025 | Showing above |
| 2024 | Nov 26, 2024 | |
| 2023 | Nov 29, 2023 | |
| 2022 | Nov 28, 2022 | |
| 2021 | Nov 22, 2021 | |
| 2020 | Nov 23, 2020 | |
| 2019 | Nov 25, 2019 | |
| 2018 | Dec 11, 2018 | |
| 2017 | Dec 12, 2017 | |
| 2016 | Dec 14, 2016 | |
| 2015 | Dec 14, 2015 | |
About PP&E Disclosures
The PP&E disclosure details a company's physical asset base — land, buildings, machinery, and equipment — along with the depreciation methods and useful life assumptions that determine how these costs flow through the income statement. Capitalization policy thresholds reveal management's judgment on the boundary between expense and asset, directly affecting both reported earnings and asset values.
Key signals: changes in estimated useful lives or depreciation methods can materially shift reported earnings without any operational change. Compare capital expenditures against depreciation expense — when capex consistently trails depreciation, the asset base may be aging and underinvested. Watch for large asset impairments or write-downs that signal overvalued carrying amounts. Asset retirement obligations reveal future environmental or decommissioning costs that are often underappreciated. Compare PP&E intensity (PP&E-to-revenue) against industry peers to assess capital efficiency and competitive positioning.